Product NDC: | 0781-2076 |
Proprietary Name: | tamsulosin hydrochloride |
Non Proprietary Name: | tamsulosin hydrochloride |
Active Ingredient(s): | .4 mg/1 & nbsp; tamsulosin hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0781-2076 |
Labeler Name: | Sandoz Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078015 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100427 |
Package NDC: | 0781-2076-10 |
Package Description: | 1000 CAPSULE in 1 BOTTLE (0781-2076-10) |
NDC Code | 0781-2076-10 |
Proprietary Name | tamsulosin hydrochloride |
Package Description | 1000 CAPSULE in 1 BOTTLE (0781-2076-10) |
Product NDC | 0781-2076 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | tamsulosin hydrochloride |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20100427 |
Marketing Category Name | ANDA |
Labeler Name | Sandoz Inc |
Substance Name | TAMSULOSIN HYDROCHLORIDE |
Strength Number | .4 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |